gmi research logo
GMI Research
See the Future Insights
GMI Research Facebook Page GMI Research Twitter Page GMI Research Linkedin Page
U.S Office +1 860 881 2270 : Europe Office +353 1 442 8820  

Influenza Vaccines Market by Vaccine Type (Quadrivalent, Trivalent), by Route of Administration (Intramuscular, Intravenous, Others), and by Geography - Global Forecast to 2021

Get Free 20% Customization in this Report


Report Code : HM01A-00-0617 Published Date: June-2017 Report Format: PPT

 

Select License Type:

Need Assitance ?


A GMI Research Sales Representative
is available to help you

U.S Office +1 860 881 2270

Europe Office +353 1 442 8820


 The influenza vaccines industry in the world is poised to experience a remarkable growth in recent years, and is offering abundant opportunities to the players in this industry. The key factors driving the growth of influenza vaccines market are increasing pandemic outbreak and rising awareness amongst consumers, followed by the rise in elderly population across the world as well as increase in affordability in emerging economies. Moreover, introduction of universal flu vaccines, increasing R&D investments, fast track approval of influenza vaccines, and rise in inorganic strategies adopted by key players are set to further assist the growth of the global influenza vaccines market.

 

The share of Asia Pacific market, in global influenza vaccines market, is anticipated to witness a significant increase, but will also experience stiff competition from European flu vaccines market. Countries in Asia Pacific including China and India are anticipated to observe astounding market growth as these are the key priorities of MNCs in flu vaccines industry. Moreover, these countries have enormous potential for influenza vaccine manufacturers in terms of huge population and high incidence rates of infectious diseases such as influenza. 
 
 
This research report displays the global influenza vaccine industry being segmented based on major vaccines that have been commercialized. Furthermore, important geographies have been highlighted along with their current and future markets outlook. This report also covers pipeline analysis of key players and other flu vaccines that are under various phases of clinical development. The report identifies and highlights the segments that suggest maximum opportunity for growth in the influenza vaccines market globally. The report also analyses the competitive landscape and the major players along with their individual market share in 2016 adjacently highlighting the recent trends or developments followed in the influenza vaccines market.
 
 
The report further profiles the major companies active in this field, including Sanofi, GlaxoSmithKline plc, CSL Ltd, AstraZeneca, Sarepta Therapeutics, Inc., Inovio Pharmaceuticals, Inc., Abbott, Janssen Global Services, LLC amongst others.
 
 
The global Influenza Vaccines market is segmented based on geography:
 
 
Global Influenza Vaccines Market by Vaccine Type
Quadrivalent 
Trivalent 
 
 
Global Influenza Vaccines Market by Route of Administration
Intramuscular
Intravenous
Others
 
 
Global Influenza Vaccines Market by Region
North America
Europe
Asia-Pacific 
RoW
 
 
Global Influenza Vaccines Market by Country
U.S.
U.K.
India
China
Brazil
 
 
Global Influenza Vaccines Market Competitive Landscape
Major Players and their Market Share Analysis
New product launches
Mergers and acquisitions, Collaborations, partnerships, agreements and Joint ventures
 
 
Free Customization upto 20% in this report
 
 

1. Executive Summary 

2. Introduction  
        2.1. Study Objectives
        2.2. Scope of the study
                2.2.1. Market Covered
                2.2.2. Geographical Coverage
                2.2.3. Forecast Data
        2.3. Research Methodology
 
3. Global Influenza Vaccines Market Overview
        3.1. Introduction
        3.2. Market Segmentation
                3.2.1         By Vaccine Type
                3.2.2         By Route of Administration
        3.3. Value Chain Analysis
        3.4. Market Drivers
        3.5. Market Restraints/Inhibitors
        3.6. Market Attractiveness and Technology Trend
 
4.        Global Influenza Vaccines Market Outlook to 2021
        4.1 By Vaccine Type
                4.1.1       Quadrivalent Vaccines
                4.1.2       Trivalent Vaccines
        4.2 By Route of Administration
                4.2.1       Intramuscular
                4.2.2       Intravenous
                4.2.3       Other 
 
5. Global Influenza Vaccines: Pipeline Analysis 
      5.1. By Phase
 
6. Global Influenza Vaccines Market by Geography
      6.1. North America
                6.1.1        By Vaccine type
                6.1.2        By Route of Administration
      6.2.       Europe
                6.2.1       By Vaccine type
                6.2.2       By Route of Administration
      6.3.       Asia-Pacific
                6.3.1.      By Vaccine Type
                6.3.2.     By Route of Administration
      6.4. Rest of the World 
                6.4.1     By Vaccine Type
7. Global Influenza Vaccines Market by Country
      7.1. United States
      7.2. United Kingdom
      7.3. China
      7.4. India
      7.5. Brazil 
8. Competitive Landscape
      8.1.   Major Players Market Share Analysis
      8.2. Porter’s Five Forces Analysis
 
9. Company Profiles
      9.1.       Sanofi
                9.1.1. Overview
                9.1.2. Financial analysis
                9.1.3. Recent Developments
      9.2.     GlaxoSmithKline plc
                9.2.1. Overview
                9.2.2. Financial analysis
                9.2.3. Recent Developments
      9.3.     CSL Limited
                9.3.1 Overview
                9.3.2. Financial analysis
                9.3.3. Recent Developments
      9.4.      AstraZeneca
                9.4.1. Overview
                9.4.2. Financial analysis
                9.4.3. Recent Developments
      9.5.      Sinovac Biotech Ltd.
                9.5.1. Overview
                9.5.2. Financial analysis
                9.5.3. Recent Developments
      9.6.     Sarepta Therapeutics, Inc.
                9.6.1. Overview
                9.6.2. Financial analysis
                9.6.3. Recent Developments
      9.7.    Novavax, Inc. 
                9.7.1. Overview
                9.7.2. Financial analysis
      9.8.      Abbott
                9.8.1. Overview
                9.8.2. Financial analysis
      9.9.      Inovio Pharmaceuticals, Inc.
                9.9.1 Overview
                9.9.2 Financial analysis
                9.9.3 Recent Developments
      9.10.    Janssen Global Services, LLC
                9.10.1. Overview
                9.10.2. Financial analysis
                9.10.3. Recent Developments
 
10. Appendix